Low expression of micropeptide HOXB-AS3 is associated with poor prognosis in CRC patients, which is explained by the fact that HOXB-AS3 micropeptide deficiency promotes aerobic glycolysis and CRC cell growth [112]. This evidence concerns the gene HOXB-AS3 and colorectal carcinoma.